Allworth Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.2M | Sell |
24,334
-10,625
| -30% | -$5.1M | 0.05% | 209 |
|
|
2026
Q1 | $17.2M | Sell |
34,959
-60
| -0.2% | -$32.6K | 0.07% | 172 |
|
|
2025
Q4 | $20.3M | Buy |
35,019
+14,110
| +67% | +$7.98M | 0.08% | 140 |
|
|
2025
Q3 | $10.1M | Buy |
20,909
+1,254
| +6% | +$584K | 0.04% | 210 |
|
|
2025
Q2 | $7.97M | Sell |
19,655
-589
| -3% | -$246K | 0.04% | 235 |
|
|
2025
Q1 | $8.64M | Buy |
20,244
+1,461
| +8% | +$791K | 0.05% | 192 |
|
|
2024
Q4 | $10.8M | Buy |
18,783
+12,160
| +184% | +$6.69M | 0.06% | 168 |
|
|
2024
Q3 | $4.1M | Buy |
6,623
+1,177
| +22% | +$697K | 0.02% | 234 |
|
|
2024
Q2 | $2.91M | Buy |
5,446
+1,978
| +57% | +$1.13M | 0.02% | 268 |
|
|
2024
Q1 | $2.02M | Buy |
3,468
+739
| +27% | +$415K | 0.01% | 318 |
|
|
2023
Q4 | $1.45M | Buy |
2,729
+385
| +16% | +$186K | 0.01% | 353 |
|
|
2023
Q3 | $1.19M | Buy |
2,344
+293
| +14% | +$156K | 0.01% | 355 |
|
|
2023
Q2 | $1.07M | Sell |
2,051
-191
| -9% | -$103K | 0.01% | 370 |
|
|
2023
Q1 | $1.29M | Buy |
2,242
+218
| +11% | +$123K | 0.01% | 321 |
|
|
2022
Q4 | $1.11M | Sell |
2,024
-370
| -15% | -$196K | 0.01% | 332 |
|
|
2022
Q3 | $1.21M | Buy |
2,394
+190
| +9% | +$106K | 0.02% | 288 |
|
|
2022
Q2 | $1.2M | Buy |
2,204
+444
| +25% | +$244K | 0.02% | 281 |
|
|
2022
Q1 | $1.04M | Buy |
1,760
+213
| +14% | +$122K | 0.01% | 300 |
|
|
2021
Q4 | $1.03M | Buy |
1,547
+230
| +17% | +$144K | 0.01% | 281 |
|
|
2021
Q3 | $752K | Buy |
1,317
+880
| +201% | +$483K | 0.01% | 272 |
|
|
2021
Q2 | $220K | Buy |
437
+125
| +40% | +$59K | ﹤0.01% | 362 |
|
|
2021
Q1 | $142K | Hold |
312
| – | – | ﹤0.01% | 400 |
|
|
2020
Q4 | $145K | Buy |
312
+46
| +17% | +$21.6K | ﹤0.01% | 318 |
|
|
2020
Q3 | $117K | Hold |
266
| – | – | ﹤0.01% | 305 |
|
|
2020
Q2 | $96K | Buy |
266
+230
| +639% | +$77.1K | ﹤0.01% | 322 |
|
|
2020
Q1 | $10K | Hold |
36
| – | – | ﹤0.01% | 707 |
|
|
2019
Q4 | $12K | Hold |
36
| – | – | ﹤0.01% | 616 |
|
|
2019
Q3 | $10K | Sell |
36
-95
| -73% | -$27.2K | ﹤0.01% | 591 |
|
|
2019
Q2 | $39K | Hold |
131
| – | – | ﹤0.01% | 365 |
|
|
2019
Q1 | $36K | Hold |
131
| – | – | ﹤0.01% | 366 |
|
|
2018
Q4 | $29K | Buy |
131
+95
| +264% | +$22.3K | ﹤0.01% | 355 |
|
|
2018
Q3 | $9K | Buy |
+36
| New | +$8.28K | ﹤0.01% | 578 |
|
Other funds holding TMO
Allworth Financial's TMO Position: Q2 2026 in Review
Allworth Financial reduced its Thermo Fisher Scientific (TMO) stake by 30% in Q2 2026, selling an estimated $5.1M and leaving 24,334 shares worth $12.2M. The position accounts for 0.05% of the portfolio, ranked #209.
Allworth Financial first reported a position in TMO in Q3 2018 and has held it in 32 quarters since. The position peaked at $20.3M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Allworth Financial held 24,334 shares of Thermo Fisher Scientific worth $12.2M as of Q2 2026.
- Allworth Financial sold 10,625 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.1M.
- Thermo Fisher Scientific made up 0.05% of Allworth Financial's portfolio in Q2 2026, its #209 holding.
- Allworth Financial first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 32 quarters since.
- Allworth Financial's Thermo Fisher Scientific position peaked at $20.3M in Q4 2025.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.